Jardiance (empagliflozin) is an SGLT2 inhibitor that works by the kidneys, increasing the amount of glucose filtered into urine rather than reabsorbed into the bloodstream
*Correspondence: ZongRan Pang, [email protected]
This detail, they wrote, limits the generalizability of the study
This may be attributed to the bodys detoxifying process or changes in the amount of glutathione, which may influence your blood pressure or water level
doi:10.1186/s12933-022-01604-7 6.Fras JP, Davies MJ, Rosenstock J, et al
For GLP-1 players looking to sustain market position and capture long-term value, strategic differentiation beyond pricing thus becomes essential